None listed
Conditions
Interventions
Medical Device : The subjects diagnosed with acute or chronic pancreatitis will be randomly assigned to either control group who will receive the conventional standard-of-care (SOC) therapy alone, or
afterwards, if inadequately controlled, low-potency narcotic analgesics such as codeine and then high-potency narcotic analgesics such as morphine will be given sequentially as required. In treatment
Sponsors
Dongguk University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? Male or female adults aged =20 years at baseline ? Patients with acute pancreatitis and at least twos of the following three findings: (1) acute abdominal pain and tenderness in the upper abdomen; (2) elevated levels pancreatic enzymes in the blood: amylase and/or lipase=3 times the upper limit of normal; or, (3) abnormal findings of acute pancreatitis detected by ultrasonography, computed tomography(CT) or magnetic resonance imaging(MRI). ? Patients with chronic pancreatitis, repeated abdominal pains and pancreatic calcifications or irregular changes in the diameter of the pancreatic duct seen on abdomen images ? Those who are able to understand fully the nature of the study as well any potential risks involved in their own participation in the study, to communicate smoothly with the investigator(s), and to adhere to the compliance details ? Those who have been provided with the appropriate information on the objectives, methods and expected therapeutic effects of the study, and have signed a written consent (informed consent form)
Exclusion criteria
Exclusion criteria: ? Patients with acute pancreatitis and another pancreatic disease or any other condition which may cause acute abdominal pain ? Patients with chronic pancreatitis and any other etiology, for example, pancreatic cancer or pancreatic cystic tumor ? Those who participate in any other clinical trial after enrollment in the study, or who have participated in any other clinical trial(s) within three months before enrollment in this study ? Those who have any trouble in questionnaire completion and communications ? Any other people who are considered by the Principal Investigator to be ineligible to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 100mm Visual Analogue Scale (VAS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain control agent demand;EuroQol five dimensions questionnaire(EQ-5D);CT(computed tomography) | — |
Countries
Korea, Republic of
Contacts
Public ContactCHANYUNG JUNG
Dongguk University
Outcome results
None listed